FDA Adverse Event Malfunction Summary report: N

14F X 36CM SPLIT STREAM

MDR report key: 2102847 · Received May 3, 2011

Report

Report Number
2518902-2011-00042
Event Type
Malfunction
Date Received
May 3, 2011
Date of Event
March 21, 2011
Report Date
April 29, 2011
Manufacturer
MEDCOMP
Product Code
LJT
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SW
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE INVOLVED IN THE EVENT WAS NOT RETURNED FOR EVAL. FROM THE DESCRIPTION OF THE EVENT THE FAILURE APPEARS TO BE ONE THAT HAS BEEN PREVIOUSLY INVESTIGATED. THE SPLIT STREAM CATHETER IS MANUFACTURED BY BONDING TWO LUMENS TOGETHER ALLOWING THE DISTAL PORTION OF THE LUMENS TO BE SEPARATED BY THE PHYSICIAN AS DEEMED APPROPRIATE. THE PROXIMAL PORTION OF THE LUMEN IS PERMANENTLY BONDED. SOME CATHETERS WERE DEVELOPING A SMALL HOLE IN THE LUMEN AT THE POINT WHERE THE LUMENS ARE PERMANENTLY BONDED TOGETHER. THE MFG PROCESS OF THE PERMANENTLY BONDED SECTION OF THE LUMENS INCLUDED A PEEL BACK STEP AFTER BONDING TO ASSURE THE CORRECT LOCATION OF THE BONDED SECTION. AFTER EVALUATING RETURNED SAMPLES IT WAS DETERMINED THAT THE PEEL BACK STEP MAY HAVE CONTRIBUTED TO THE WEAKENING OF LUMEN WALL TO THE POINT OF THAT HOLE MAY DEVELOPED OVER TIME IN THE FIELD. CHANGES HAVE BEEN IMPLEMENTED TO THE MFG PROCESS THAT WILL MINIMIZE THE SPREADING OF THE BONDING AGENT PASS THE PERMANENTLY BONDED SECTION THEREFORE ELIMINATING THE PEEL BACK STEP. A TRIAL WAS CONDUCTED USING THE IMPROVED PROCESS. ALL CATHETERS MET ALL ACCEPTANCE CRITERIA, VISUAL, DIMENSION, AND LEAK TEST. THE CATHETER INVOLVED IN THIS INCIDENT WAS MANUFACTURED PRIOR TO THE PROCESS CHANGE.

Description of Event or Problem · 1

IT WAS REPORTED THAT THERE WAS "LEAKAGE OF BLOOD, WHERE EXTENSIONS ARE CONNECTED TO THE CATHETER, DURING TREATMENT." NO ILL EFFECTS TO THE PT WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 14F X 36CM SPLIT STREAM HEMODIALYSIS CATHETER LJT MEDCOMP SST36E. MART130

Patients

Seq Age Sex Outcome Treatment
1 71 YR Required Intervention